Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Judi Lynn

(163,098 posts)
Mon Feb 24, 2025, 03:53 AM Feb 24

Popular Weight Loss Drugs Linked to Blindness, New Study Finds

By
Nisha Zahid
February 12, 2025

Health experts are investigating whether popular weight loss drugs like Ozempic, Wegovy and Mounjaro could be linked to sudden blindness in some patients.

A recent report in JAMA Ophthalmology detailed nine cases of U.S. patients who lost their sight after using drugs containing semaglutide or tirzepatide, the active ingredients in these medications. While researchers cannot confirm the drugs directly caused blindness, they say the findings warrant further study.

Cases of Sudden Vision Loss
One woman in her 50s lost sight in her left eye just one day after her first semaglutide injection for diabetes. Frightened, she stopped the drug for two months, but when she resumed treatment, she went blind in her right eye, too.

Another woman, who had taken semaglutide for a year, awoke with a dark shadow over her left eye. Doctors found damage to retinal blood vessels, leading to blindness.

A man in his 60s who was using semaglutide for 10 months noticed the vision in his right eye was getting blurry. Tests showed optic nerve swelling and bleeding in his retina. Though his symptoms improved within weeks, he eventually lost vision in his left eye. His sight returned after he stopped taking the drug for 10 weeks.

More:
https://greekreporter.com/2025/02/12/weight-loss-drugs-blindness/

2 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Popular Weight Loss Drugs Linked to Blindness, New Study Finds (Original Post) Judi Lynn Feb 24 OP
Frightening! Deserves xpost in GD and Health as well. nt eppur_se_muova Feb 24 #1
I take semaglutide, a choice to which my wife mildly objects. One needs, where adverse events, both discovered in... NNadir Feb 26 #2

NNadir

(35,301 posts)
2. I take semaglutide, a choice to which my wife mildly objects. One needs, where adverse events, both discovered in...
Wed Feb 26, 2025, 12:50 AM
Feb 26

...clinical trials and those discovered in "phase IV" safety monitoring of approved drugs, to compare the relative risks with the risks of not taking a drug.

I have a familial risk of type 2 diabetes, along with a familial history of obesity, the latter having manifested itself relatively late in life, having previously been managed by the famous invective of "diet and exercise." As I age, and as my professional responsibilities have multiplied, my creaky bones and demands on my time have basically precluded, diet and exercise.

My grandfather, who had access to neither commonly available medications like metformin, or for that matter, semaglutide, lost his legs shortly before dying from diabetes.

My wife, who doesn't like me injecting myself - or asking her to inject me - with semaglutide every Sunday, made sure I heard about the blindness thing. On the other hand, I decided to take semaglutide after hearing a scientific lecture on GLP-1 peptides on the topic at a scientific meeting.

I have a genetic susceptibility to Barrett's esophagus, which is why my father and my uncle, both heavy smokers (which I am not) got esophageal cancer before lung cancer. Mechanistically, esophageal cancer is initiated by nitrosamines, which have been identified as impurities in certain formulations of metformin. Knowing this, I still take metformin.

There are millions of people who take GLP-1 drugs, and given their modes of action - they are glucagon isosteres as opposed to insulin isosteres, but clearly are interactive peptide hormones - it's not entirely surprising that a subset face risks of this type, circulatory effects, expressed in the eyes, since insulin a generated from proinsulin where the cleaved peptide is responsible for preventing the venous responses that lead to limb atrophy, and ultimately amputation, as in my grandfather's case. It is therefore not entirely surprising that agonist effects of what is, basically, a peptide, balance in such a way as antagonist effects to produce a side effect.

The real question is, however, is how many of the people who take GLP-1 drugs, numbering now in the tens of millions, would have died from complications of obesity and diabetes, without the drug, compared with the number of persons who have had vision effects.

All questions of this type, whether in medicine or in energy science, need to be examined on a risk benefit basis. I can't think of any drug that is risk free. Hell, there aren't many foods that are risk free. A risk associated with not taking the drug may be worse (death) than the risk of blindness, which is apparently very low given the number of instances of reported blindness and the size of the populations using the drugs.

Latest Discussions»Culture Forums»Science»Popular Weight Loss Drugs...